Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Ascendis Pharma Gets FDA Approval for Yuviwel
Ascendis Pharma secured Food and Drug Administration approval under the agency's accelerated approval program for Yuviwel, a treatment for the genetic condition that causes dwarfism. The approval is for children 2 years and older with…
Disclosure of a transparency notification from AOC Pharma S.à r.l.
Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in listed…
Pharma Drives Swiss Growth Recovery After US Tariff Shock
Switzerland's pharmaceutical industry drove a recovery after outsized US tariffs plunged its export-focused economy into only the second contraction since the pandemic. Expansion of 1.9% among manufacturers of drugs and chemicals contributed…
Why Dupixent Keeps Regeneron Stock A Top Big Pharma Pick (NASDAQ:REGN)
Regeneron Pharmaceuticals ended 2025 and started this year on a high note. Regeneron and its partner Sanofi are among the leaders in the immune-mediated inflammatory diseases market. In Q4, Dupixent sales grew 22.8% year-on-year and 2.2%…
ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript
President and Chief Executive Officer — Nikhil Lalwani Senior Vice President and Chief Financial Officer — Stephen Carey Senior Vice President and Head of Rare Disease — Christopher Mutz Need a quote from a Motley Fool analyst?
Blue Jet Healthcare to set Rs ₹2,300 cr pharma plant AP
Blue Jet Healthcare is setting up a greenfield pharmaceutical manufacturing facility at Rambilli Industrial Park in Anakapalli district, Andhra Pradesh. The ground-breaking ceremony of the plant will take place on February 28, 2026. The Rambilli…
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of 'Hold' by Analysts
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of 'Hold' from the seven brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock…
Astellas Pharma (OTCMKTS:ALPMY) Sees Large Volume Increase - Here's Why
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) shares saw an uptick in trading volume on Friday. 294,592 shares changed hands during mid-day trading, an increase of 116% from the previous session's volume of 136,389 shares.The stock last…
Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week High - What's Next?
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Friday. The company traded as high as $46.37 and last traded at $46.1250, with a volume of 1008568 shares changing hands. The stock had previously closed…
Astellas Pharma (OTCMKTS:ALPMY) Sees Strong Trading Volume - Here's What Happened
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) shares saw unusually-high trading volume on Friday. Approximately 294,592 shares changed hands during mid-day trading, an increase of 116% from the previous session's volume of 136,389…
Vaccine Developer Bharat Biotech Said To Consider $500 Million IPO
Bharat Biotech IPO: Vaccine developer Bharat Biotech International Ltd is mulling over a public listing that is expected to raise over $500 million. These deliberations are currently underway, including the lot size ford different categories, and…
Artisan Partners Limited Partnership Has $739.75 Million Stock Position in Ascendis Pharma A/S $ASND
Artisan Partners Limited Partnership lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 6.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Stock Market Today Feb 27, 2026 ' Sensex tanks 961 points, Nifty50 Falls 1.25%
Indian stock markets faced a sharp downturn as Sensex and Nifty tumbled, driven by foreign fund outflows, geopolitical tensions, and uncertainty surrounding US-Iran nuclear talks. Sensex and Nifty plunged over 1% due to foreign fund outflows and…
Trump most-favored nation drug pricing deals end after three years for some companies
WASHINGTON — President Trump often brags that the “most-favored nation” deals he struck with drugmakers have set the country on a new path to no longer paying more than its fair share for prescription drug costs. But many…
Two Boston startups join the race to create the next major weight-loss drug
Two major pharmaceutical companies have tapped two Boston area startups in their bid to create the next big oral weight-loss drug, as demand for GLP-1 medications skyrockets. Earlier this week, the Danish multinational pharmaceutical company Novo…
Receive a Daily briefing on Pharma Industry News
Get Started